Aller au contenu
GeoClinicalTrials
Retour à la recherche

NCT06931847Pas encore en recrutement

SUNRISE Aims to Create a Comprehensive, Engaging, and Sustainable Digital Health Promotion Program That Not Only Addresses Immediate Health Behaviours But Also Instils Lifelong Healthy Habits Among Adolescents. It is a Unique, Digitally Enhanced Program Combining Different Digital Solutions With New

Fiche officielleVersion simplifiée

Résumé

SUNRISE aims to create a comprehensive, engaging, and sustainable digital health promotion program that not only addresses immediate health behaviours but also instills lifelong healthy habits among adolescents. By integrating cutting-edge digital tools with traditional educational settings, SUNRISE seeks to bridge the gap between knowledge and practice, making cancer prevention a tangible and achievable goal for young people. This study represents a significant step towards reducing the future burden of cancer through early and innovative preventive measures. The SUNRISE project aims to test its interventions on students across eight European countries, including Greece, Switzerland, Slovenia, Spain, Cyprus, Italy, Belgium, and Romania. This study focuses on integrating a unique, digitally enhanced program combining different digital solutions with new methods to change adolescent health behaviour through social media campaigns, social bot platforms, educational games, and health-related advertising content into the school environment, targeting students aged 10 to 19 years. The program emphasizes inclusivity, ensuring participation from both urban and rural regions and socially disadvantaged groups such as ethnic minorities and migrants. By addressing diverse socio-economic, cultural, and environmental contexts, SUNRISE aspires to create a universally applicable and impactful intervention.

Critères d'inclusion

• Minimum Age: Students must be at least 10 years old at the time of enrolment. • Devices and Internet Access: Students must have access to an electronic device with Internet connectivity. • Informed Consent: Students must provide their signed informed consent to participate in the study. • Parental Consent: Students, when necessary, must obtain and submit signed informed consent from a parent or legal guardian.

Critères d'exclusion

• Age Restrictions: Students who are younger than 10 years or older than the established age range for participation. • Consent Issues: Students who have not signed the informed consent form or do not have signed informed consent from their parents or legal guardians. • Follow-up Limitations: Students who are unable to commit to the follow-up period of at least 18 months or are unlikely to complete the study.

Contacts

Les coordonnées de l'équipe de l'essai s'affichent sur demande.

Voir la fiche officielle de l'essai
Statut
Pas encore en recrutement
Phase
—
Type d'étude
Observationnelle
Pays
Suisse, Italie, Belgique, Chypre, Grèce, Roumanie, Slovénie, Espagne
Promoteur
Biobizkaia Health Research Institute(Autre gouvernement)
N° de protocole
SUNRISE_Study2
Pathologies
Cancer
Interventions
Autre

Traitements évalués

  • SUNRISE program

Collaborateurs

FEDERAZIONE ITALIANA DELLE ASSOCIAZIONI DI VOLONTARIATO IN ONCOLOGIA, Hellenic Mediterranean University, University Ghent, University of Zurich, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana, The Oncology Institute "Prof. Dr. Ion Chiricuţă" Cluj-Napoca, Cyprus Association of Cancer Patients and Friends (PASYKAF), Alma Mater Europaea - Slovenia

Lieux · 8

  • Zurich, SuisseSwiss Research Institute for Public Health and Addiction (ISGF)Recrutement pas encore ouvert dans ce centre
  • Roma, ItalieItalian Federation of Voluntary Associations in Oncology (FAVO)Recrutement pas encore ouvert dans ce centre
  • Zürich, BelgiqueGhent University (UGENT)Recrutement pas encore ouvert dans ce centre
  • Nicosia, ChypreCyprus Association of Cancer Patients and Friends (PASYKAF)Recrutement pas encore ouvert dans ce centre
  • Heraklion, GrèceHellenic Mediterranean University (HMU)Recrutement pas encore ouvert dans ce centre
  • Cluj-Napoca, RoumanieInstitute of Oncology "Prof dr. Ion Chiricuta" CLUJ NAPOCA (IOCN)Recrutement pas encore ouvert dans ce centre
  • Maribor, SlovénieAlma Mater Europaea University (AMEU)Recrutement pas encore ouvert dans ce centre
  • Valencia, EspagneFoundation for the Promotion of Health and Biomedical Research of the Valencian Community (Fisabio)Recrutement pas encore ouvert dans ce centre

Au total, dans le monde, les 8 centres listés au registre sont prévus ; le recrutement n'est pas encore ouvert.

Statut par centre selon le registre ClinicalTrials.gov (dernière mise à jour publiée : 17 avril 2025).

Ce statut peut avoir changé et ne dit rien de votre éligibilité : avant toute démarche, vérifiez avec votre oncologue ou le centre.

Autres identifiants

  • PI2024216 · autre identifiant

Voir aussi

Autres versions

Ces résultats sont indicatifs et ne remplacent pas un avis médical — à discuter avec votre médecin.